StockData
NovoCure Ltd logo

NovoCure Ltd (NVCR) income statement

NVCRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3033% below fair value
$10.73−0.41 (-3.68%)

Close on Nov 18, 2026Market cap $1.25BP/E –Yield –

NovoCure Ltd income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
77.0%
Operating margin
-17.2%
Net margin
-16.8%
Return on equity, FY2025
-38.9%

Financial strength

Current ratio
2.49
Debt to equity
–
Debt to assets
–
Cash to current liabilities
35.7%

Valuation

P/E ratio
–
Price to sales
1.73
Price to book
3.58
Dividend yield
–

See a number that looks wrong?